We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Article |

Systemic Chemotherapy For CNS Metastases Of Solid Tumors

Arch Intern Med. 1965;115(6):710-713. doi:10.1001/archinte.1960.03860180082014.
Text Size: A A A
Published online


ALTHOUGH not widely accepted, systemic chemotherapy in patients with metastatic malignancies of the central nervous system (CNS) is feasible and can offer excellent palliation. Systemic therapy is preferred to regional therapy because most, if not all, of these patients have other metastatic disease. A review of the literature on the treatment of metastatic CNS lesions revealed little information. Three articles on perfusion with alkylating agents (Woodhall et al,1 Mark et al,2 and Perese et al3) were directed primarily to technique. Chu and Hilaris 4 used irradiation for CNS lesions and noted improvement in a variety of malignancies, by means of local therapy. Davis and Shumway 5 reported intra-arterial (carotid) injection of triethylenethiophosphoramide in a series of patients. This study included 31 men with carcinoma of the lung and 66 women with carcinoma of the breast. Triethylenethiophosphoramide was injected into the carotid artery on the involved side at


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview





Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.